TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex

Epithelioid hemangioendothelioma (EHE) is a vascular sarcoma that metastasizes early in its clinical course and lacks an effective medical therapy. The TAZ-CAMTA1 and YAP-TFE3 fusion proteins are chimeric transcription factors and initiating oncogenic drivers of EHE. A combined proteomic/genetic scr...

Full description

Bibliographic Details
Main Authors: Nicole Merritt, Keith Garcia, Dushyandi Rajendran, Zhen-Yuan Lin, Xiaomeng Zhang, Katrina A Mitchell, Nicholas Borcherding, Colleen Fullenkamp, Michael S Chimenti, Anne-Claude Gingras, Kieran F Harvey, Munir R Tanas
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2021-04-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/62857
_version_ 1811236848951885824
author Nicole Merritt
Keith Garcia
Dushyandi Rajendran
Zhen-Yuan Lin
Xiaomeng Zhang
Katrina A Mitchell
Nicholas Borcherding
Colleen Fullenkamp
Michael S Chimenti
Anne-Claude Gingras
Kieran F Harvey
Munir R Tanas
author_facet Nicole Merritt
Keith Garcia
Dushyandi Rajendran
Zhen-Yuan Lin
Xiaomeng Zhang
Katrina A Mitchell
Nicholas Borcherding
Colleen Fullenkamp
Michael S Chimenti
Anne-Claude Gingras
Kieran F Harvey
Munir R Tanas
author_sort Nicole Merritt
collection DOAJ
description Epithelioid hemangioendothelioma (EHE) is a vascular sarcoma that metastasizes early in its clinical course and lacks an effective medical therapy. The TAZ-CAMTA1 and YAP-TFE3 fusion proteins are chimeric transcription factors and initiating oncogenic drivers of EHE. A combined proteomic/genetic screen in human cell lines identified YEATS2 and ZZZ3, components of the Ada2a-containing histone acetyltransferase (ATAC) complex, as key interactors of both fusion proteins despite the dissimilarity of the C terminal fusion partners CAMTA1 and TFE3. Integrative next-generation sequencing approaches in human and murine cell lines showed that the fusion proteins drive a unique transcriptome by simultaneously hyperactivating a TEAD-based transcriptional program and modulating the chromatin environment via interaction with the ATAC complex. Interaction of the ATAC complex with both fusion proteins indicates that it is a key oncogenic driver and unifying enzymatic therapeutic target for this sarcoma. This study presents an approach to mechanistically dissect how chimeric transcription factors drive the formation of human cancers.
first_indexed 2024-04-12T12:15:09Z
format Article
id doaj.art-f5236ab6208a49dc9d2f318dd8878eee
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-04-12T12:15:09Z
publishDate 2021-04-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-f5236ab6208a49dc9d2f318dd8878eee2022-12-22T03:33:27ZengeLife Sciences Publications LtdeLife2050-084X2021-04-011010.7554/eLife.62857TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complexNicole Merritt0Keith Garcia1https://orcid.org/0000-0002-6078-5159Dushyandi Rajendran2Zhen-Yuan Lin3Xiaomeng Zhang4Katrina A Mitchell5Nicholas Borcherding6Colleen Fullenkamp7Michael S Chimenti8Anne-Claude Gingras9https://orcid.org/0000-0002-6090-4437Kieran F Harvey10Munir R Tanas11https://orcid.org/0000-0002-6779-2642Department of Pathology, University of Iowa, Iowa City, United StatesDepartment of Pathology, University of Iowa, Iowa City, United States; Cancer Biology Graduate Program, University of Iowa, Iowa City, United StatesLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, United StatesLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, United StatesPeter MacCallum Cancer Centre, Melbourne, AustraliaPeter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, AustraliaDepartment of Pathology and Immunology, Washington University, St. Louis, United StatesDepartment of Pathology, University of Iowa, Iowa City, United StatesIowa Institute of Human Genetics, Carver College of Medicine, University of Iowa, Iowa City, United StatesLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, United StatesPeter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia; Department of Anatomy and Developmental Biology and Biomedicine Discovery Institute, Monash University, Clayton, AustraliaDepartment of Pathology, University of Iowa, Iowa City, United States; Cancer Biology Graduate Program, University of Iowa, Iowa City, United States; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, United States; Pathology and Laboratory Medicine, Veterans Affairs Medical Center, Iowa City, United StatesEpithelioid hemangioendothelioma (EHE) is a vascular sarcoma that metastasizes early in its clinical course and lacks an effective medical therapy. The TAZ-CAMTA1 and YAP-TFE3 fusion proteins are chimeric transcription factors and initiating oncogenic drivers of EHE. A combined proteomic/genetic screen in human cell lines identified YEATS2 and ZZZ3, components of the Ada2a-containing histone acetyltransferase (ATAC) complex, as key interactors of both fusion proteins despite the dissimilarity of the C terminal fusion partners CAMTA1 and TFE3. Integrative next-generation sequencing approaches in human and murine cell lines showed that the fusion proteins drive a unique transcriptome by simultaneously hyperactivating a TEAD-based transcriptional program and modulating the chromatin environment via interaction with the ATAC complex. Interaction of the ATAC complex with both fusion proteins indicates that it is a key oncogenic driver and unifying enzymatic therapeutic target for this sarcoma. This study presents an approach to mechanistically dissect how chimeric transcription factors drive the formation of human cancers.https://elifesciences.org/articles/62857hippo pathwaysarcomaschimeric transcription factorsfusion proteinsepigeneticsATAC complex
spellingShingle Nicole Merritt
Keith Garcia
Dushyandi Rajendran
Zhen-Yuan Lin
Xiaomeng Zhang
Katrina A Mitchell
Nicholas Borcherding
Colleen Fullenkamp
Michael S Chimenti
Anne-Claude Gingras
Kieran F Harvey
Munir R Tanas
TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
eLife
hippo pathway
sarcomas
chimeric transcription factors
fusion proteins
epigenetics
ATAC complex
title TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
title_full TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
title_fullStr TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
title_full_unstemmed TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
title_short TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
title_sort taz camta1 and yap tfe3 alter the taz yap transcriptome by recruiting the atac histone acetyltransferase complex
topic hippo pathway
sarcomas
chimeric transcription factors
fusion proteins
epigenetics
ATAC complex
url https://elifesciences.org/articles/62857
work_keys_str_mv AT nicolemerritt tazcamta1andyaptfe3alterthetazyaptranscriptomebyrecruitingtheatachistoneacetyltransferasecomplex
AT keithgarcia tazcamta1andyaptfe3alterthetazyaptranscriptomebyrecruitingtheatachistoneacetyltransferasecomplex
AT dushyandirajendran tazcamta1andyaptfe3alterthetazyaptranscriptomebyrecruitingtheatachistoneacetyltransferasecomplex
AT zhenyuanlin tazcamta1andyaptfe3alterthetazyaptranscriptomebyrecruitingtheatachistoneacetyltransferasecomplex
AT xiaomengzhang tazcamta1andyaptfe3alterthetazyaptranscriptomebyrecruitingtheatachistoneacetyltransferasecomplex
AT katrinaamitchell tazcamta1andyaptfe3alterthetazyaptranscriptomebyrecruitingtheatachistoneacetyltransferasecomplex
AT nicholasborcherding tazcamta1andyaptfe3alterthetazyaptranscriptomebyrecruitingtheatachistoneacetyltransferasecomplex
AT colleenfullenkamp tazcamta1andyaptfe3alterthetazyaptranscriptomebyrecruitingtheatachistoneacetyltransferasecomplex
AT michaelschimenti tazcamta1andyaptfe3alterthetazyaptranscriptomebyrecruitingtheatachistoneacetyltransferasecomplex
AT anneclaudegingras tazcamta1andyaptfe3alterthetazyaptranscriptomebyrecruitingtheatachistoneacetyltransferasecomplex
AT kieranfharvey tazcamta1andyaptfe3alterthetazyaptranscriptomebyrecruitingtheatachistoneacetyltransferasecomplex
AT munirrtanas tazcamta1andyaptfe3alterthetazyaptranscriptomebyrecruitingtheatachistoneacetyltransferasecomplex